Mabthera and condition aggravated Patient Reports February 12, 2012

Mabthera Side Effects Report #4661234-4
Mabthera side effect was reported by a Physician from on May 05, 2005. Male patient was diagnosed with waldenstrom's macroglobulinaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood immunoglobulin m increased, condition aggravated, confusional state, incontinence, infection , lobar pneumonia, mobility decreased, monoclonal immunoglobulin present, progressive supranuclear palsy . Mabthera dosage: unknown. During the same period patient was treated with ANTIBIOTICS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5268672-X
Mabthera side effect was reported by a Physician from SWEDEN on Feb 26, 2007. Female patient, child -1 years of age, was diagnosed with vasculitis  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, no therapeutic response, progressive multifocal leukoencephalopathy. Mabthera dosage: 1000 MG, X2, UNK. Patient recovered.

Mabthera Side Effects Report #5312795-3
Mabthera side effect was reported by a Consumer or non-health professional from SERBIA AND MONTENEGRO on Apr 18, 2007. Female patient, 30 years of age, was diagnosed with thrombocytopenia, wolff-parkinson-white syndrome and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, dialysis , enterocolitis bacterial, epistaxis, glomerulonephritis, histiocytosis haematophagic, pneumonia , purpura, respiratory distress. Mabthera dosage: 500 MG, SINGLE. During the same period patient was treated with AMIODARONE, METHYLPREDNISOLONE. Patient died on 02/01/2007.

Mabthera Side Effects Report #5217204-0
Mabthera side effect was reported by a Physician from FRANCE on Jan 08, 2007. Male patient, 71 years of age, was diagnosed with rheumatoid arthritis  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: asthenia, chills, condition aggravated, delusion, depression , hot flush, infusion related reaction, sedation. Mabthera dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS, ANTIDEPRESSANT NOS, TRANQUILIZER NOS. Patient recovered.


Mabthera Side Effects Report #5133234-1
Mabthera side effect was reported by a Physician from GERMANY on Oct 05, 2006. Male patient, 65 years of age, was diagnosed with rheumatoid arthritis  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, mycoplasma infection, pneumocystis jiroveci infection, psoriasis. Mabthera dosage: unknown. Patient recovered.

Mabthera Side Effects Report #5233443-7
Mabthera side effect was reported by a Physician from SWITZERLAND on Jan 24, 2007. Female patient, 58 years of age, was diagnosed with rheumatoid arthritis  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, condition aggravated. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5269429-6
Mabthera side effect was reported by a Physician from FRANCE on Mar 05, 2007. Male patient, 56 years of age, was diagnosed with rheumatoid arthritis  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, platelet count decreased, rheumatoid arthritis . Mabthera dosage: unknown. During the same period patient was treated with CORTICOID, MOSCONTIN, AMLODIPINE BESYLATE, SECTRAL, COZAAR, VERCYTE, PLAVIX, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5097767-9
Mabthera side effect was reported by a Physician from AUSTRALIA on Aug 24, 2006. Female patient was diagnosed with rheumatoid arthritis  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: breast cancer female, condition aggravated, rheumatoid arthritis . Mabthera dosage: 1250 MG, INTRAVENOUS. During the same period patient was treated with PREMARIN, PREDNISONE, METHOTREXATE, SULFASALAZINE, HYDROXYCHLOROQUINE, PLAVIX, OMEPRAZOLE, LIPITOR. Patient recovered.

Mabthera Side Effects Report #5129805-9
Mabthera side effect was reported by a Physician from FINLAND on Sept 29, 2006. Male patient was diagnosed with rheumatoid arthritis  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: arthritis , c-reactive protein increased, condition aggravated, pyrexia. Mabthera dosage: 500 MG INTRAVENOUS. During the same period patient was treated with GLUCOCORTICOID, METHOTREXATE, ACETAMINOPHEN, CETIRIZINE, CORTISONE. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #5133232-8
Mabthera side effect was reported by a Physician from AUSTRALIA on Oct 16, 2006. Female patient was diagnosed with rheumatoid arthritis  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: arthritis , breast cancer female, condition aggravated. Mabthera dosage: 1250 MG, INTRAVENOUS. During the same period patient was treated with PREMARIN, PREDNISONE, METHOTREXATE, SULFASALAZINE, HYDROXYCHLOROQUINE, PLAVIX, OMEPRAZOLE, LIPITOR. Patient recovered.

Mabthera Side Effects Report #5157956-1
Mabthera side effect was reported by a Physician from GERMANY on Oct 27, 2006. Female patient, weighting 131.4 lb, was diagnosed with rheumatoid arthritis  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, pulmonary fibrosis , respiratory failure. Mabthera dosage: 1000 MG, Q2W, UNK. During the same period patient was treated with AZATHIOPRIN, RISEDRONATE. Patient died.

Mabthera Side Effects Report #5013931-9
Mabthera side effect was reported by a Physician from POLAND on May 15, 2006. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, renal failure chronic. Mabthera dosage: 600 MG, UNK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE. Patient died on 04/27/2006.

Mabthera Side Effects Report #5023211-3
Mabthera side effect was reported by a Physician from SPAIN on June 01, 2006. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cerebral toxoplasmosis, condition aggravated, immunodeficiency. Mabthera dosage: 375 MG/M2. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE. Patient recovered.

Mabthera Side Effects Report #5030363-8
Mabthera side effect was reported by a Physician from POLAND on June 01, 2006. Male patient was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood uric acid increased, condition aggravated, dialysis , renal failure chronic, tumour lysis syndrome. Mabthera dosage: 600 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE. Patient died on 04/27/2006.


Mabthera Side Effects Report #4565923-1
Mabthera side effect was reported by a Physician from on Jan 17, 2005. Male patient, 58 years of age, weighting 145.5 lb, was diagnosed with mantle cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bone marrow disorder, condition aggravated, mantle cell lymphoma recurrent, neutropenia, thrombocytopenia. Mabthera dosage: unknown. During the same period patient was treated with THALIDOMIDE, BACTRIMTE, ALLOPURINOL, ORACILLIN, VALACYCLOVIR. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5127268-0
Mabthera side effect was reported by a Physician from FRANCE on Sept 28, 2006. Male patient, child 4 years of age, was diagnosed with lymphoproliferative disorder and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, encephalitis , encephalopathy, nuclear magnetic resonance imaging brain abnormal, viral infection . Mabthera dosage: unknown. During the same period patient was treated with PROGRAF. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4603633-2
Mabthera side effect was reported by a Physician from on Feb 24, 2005. Male patient, 73 years of age, weighting 172.0 lb, was diagnosed with lymphoplasmacytoid lymphoma/immunocytoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bronchial obstruction, condition aggravated, confusional state, tremor. Mabthera dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, ATARAX, HYDROCORTISONE, LANSOPRAZOLE, MOVICOL, RISPERDAL, FUROSEMIDE, ADALAT OROS. Patient recovered.

Mabthera Side Effects Report #4553072-8
Mabthera side effect was reported by a Health Professional from on Dec 03, 2004. Male patient, 61 years of age, weighting 154.3 lb, was diagnosed with lymphoplasmacytoid lymphoma/immunocytoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, hepatitis b . Mabthera dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, PREDNISONE. Patient was hospitalized. Patient died on 11/29/2004.

Mabthera Side Effects Report #5117914-X
Mabthera side effect was reported by a Health Professional from GERMANY on Sept 13, 2006. Female patient, weighting 143.3 lb, was diagnosed with lymphoma  and was treated with Mabthera. After drug was administered, patient experienced the following side effects: candidiasis, condition aggravated, haematocrit decreased, haemoglobin decreased, mucosal inflammation, oral intake reduced. Mabthera dosage: 645 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, PANTOPRAZOLE. Patient was hospitalized. Patient died on 08/28/2006.


Mabthera Side Effects Report #5278715-5
Mabthera side effect was reported by a Physician from GREECE on Mar 05, 2007. Male patient, 49 years of age, weighting 207.2 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: bronchospasm, chills, condition aggravated, dyspnoea, hypoxia, infusion related reaction, pyrexia. Mabthera dosage: 100 MG, INTRAVENOUS. During the same period patient was treated with MORPHINE, CORTISONE, ALLOPURINOL, LAMIVUDINE, CEFTRIAXONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5278718-0
Mabthera side effect was reported by a Health Professional from GREECE on Mar 05, 2007. Male patient, 49 years of age, weighting 207.2 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, renal failure. Mabthera dosage: 100 MG, INTRAVENOUS. During the same period patient was treated with MORPHINE SULPHATE, CORTISONE, ALLOPURINOL, LAMIVUDINE, CEFTRIAXONE, EPINEPHRINE, HYDROCORTISONE SUCCINATE. Patient died on 03/06/2007.

Mabthera Side Effects Report #4698401-X
Mabthera side effect was reported by a Physician from on June 16, 2005. Female patient, 79 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, neutropenia, urinary tract infection . Mabthera dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, PHENERGAN, PREDNISONE. Patient recovered.

Mabthera Side Effects Report #4595876-1
Mabthera side effect was reported by a Physician from on Feb 15, 2005. Male patient, 69 years of age, weighting 242.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, dysphagia, erysipelas, infection . Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, NORVASC, DYTIDE, NEUPOGEN, NEXIUM. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4825004-6
Mabthera side effect was reported by a Consumer or non-health professional from FRANCE on Oct 26, 2005. Male patient, 56 years of age, was diagnosed with castleman's disease and was treated with Mabthera. After drug was administered, patient experienced the following side effects: c-reactive protein increased, castleman's disease, condition aggravated, dyspnoea, hepatosplenomegaly, hyperhidrosis, kaposi's sarcoma , malaise. Mabthera dosage: 375 MG/M2, SINGLE, UNK; 375 MG/M2, 1/WEEK, UNK. During the same period patient was treated with ETOPOSIDE, ANTIRETROVIRALS. Patient recovered.


Mabthera Side Effects Report #5136804-X
Mabthera side effect was reported by a Physician from SPAIN on Oct 09, 2006. Male patient, 46 years of age, was diagnosed with castleman's disease and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, kaposi's sarcoma . Mabthera dosage: 375 MG/M2, 1/WEEK. During the same period patient was treated with EFAVIRENZ, DIDANOSINE, LAMIVUDINE. Patient recovered.

Mabthera Side Effects Report #5076269-X
Mabthera side effect was reported by a Health Professional from FRANCE on Aug 03, 2006. Male patient was diagnosed with castleman's disease and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, autoimmune neutropenia, castleman's disease, condition aggravated, cyclic neutropenia, histiocytosis haematophagic, humoral immune defect, hypoxia. Mabthera dosage: 375 MG/M2, 4/WEEK. During the same period patient was treated with VINBLASTINE SULPHATE, EFAVIRENZ, AMPRENAVIR, LOPINAVIR. Patient died.

Mabthera Side Effects Report #4825055-1
Mabthera side effect was reported by a Consumer or non-health professional from FRANCE on Oct 26, 2005. Male patient was diagnosed with castleman's disease and was treated with Mabthera. After drug was administered, patient experienced the following side effects: castleman's disease, condition aggravated, disease recurrence, hepatosplenomegaly, kaposi's sarcoma . Mabthera dosage: unknown. During the same period patient was treated with ETOPOSIDE. Patient recovered.

Mabthera Side Effects Report #5009185-X
Mabthera side effect was reported by a Health Professional from SPAIN on Apr 27, 2006. Male patient, 43 years of age, weighting 163.1 lb, was diagnosed with burkitt's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood culture positive, condition aggravated, cough, hypotension, pseudomonal bacteraemia, sepsis , tachycardia, tachypnoea. Mabthera dosage: 650 MG, INTRAVENOUS. Patient died on 04/04/2006.

Mabthera Side Effects Report #4933957-0
Mabthera side effect was reported by a Health Professional from DENMARK on Feb 18, 2006. Female patient, 46 years of age, was diagnosed with basedow's disease and was treated with Mabthera. After drug was administered, patient experienced the following side effects: abnormal faeces, arthralgia, back pain , condition aggravated, frequent bowel movements, haematochezia, inflammatory bowel disease, laboratory test abnormal, pericarditis. Mabthera dosage: 750 MG, 1/WEEK, INTRAVENOUS. During the same period patient was treated with THIAMAZOLE, CENTYL, ENALAPRIL MALEATE. Patient was hospitalized and became disabled. Patient recovered.


Mabthera Side Effects Report #5009862-0
Mabthera side effect was reported by a Physician from FRANCE on May 10, 2006. Male patient, 76 years of age, weighting 213.8 lb, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, diffuse large b-cell lymphoma, infected skin ulcer, lung neoplasm malignant, metastases to adrenals, metastases to central nervous system, pancytopenia, superinfection. Mabthera dosage: 375 MG/M2, 1/MONTH, INTRAVENOUS ; Q3M. During the same period patient was treated with CHLORAMINOPHENE, FLUDARABINE, FIALURIDINE, NEUPOGEN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5030374-2
Mabthera side effect was reported by a Health Professional from DENMARK on May 30, 2006. Male patient, 73 years of age, weighting 121.3 lb, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: asthenia, condition aggravated, dyspnoea, lung infiltration, respiratory disorder. Mabthera dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ONCOVIN, PREDNISOLONE. Patient died on 05/19/2006.

Mabthera Side Effects Report #4974658-2
Mabthera side effect was reported by a Physician from FRANCE on Mar 30, 2006. Male patient was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: b-cell lymphoma, condition aggravated, iatrogenic injury, lung neoplasm malignant, metastases to adrenals, metastases to central nervous system, pancytopenia, pneumothorax traumatic, procedural complication. Mabthera dosage: unknown. During the same period patient was treated with CHLORAMINOPHENE, FIALURIDINE, NEUPOGEN, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4897058-2
Mabthera side effect was reported by a Consumer or non-health professional from POLAND on Jan 17, 2006. Female patient, 80 years of age, weighting 143.3 lb, was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, condition aggravated, platelet count decreased, pneumonia , shock, white blood cell count decreased. Mabthera dosage: 600 MG, QD, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5189956-X
Mabthera side effect was reported by a Physician from SWEDEN on Dec 07, 2006. Female patient, 67 years of age, was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, erysipelas, psoriasis. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.


Mabthera Side Effects Report #4678150-4
Mabthera side effect was reported by a Physician from on May 20, 2005. Male patient was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, hypertension, transient ischaemic attack. Mabthera dosage: unknown. Patient recovered.